Showing results (41-50 of 60) with videos related to
Sort By:
Pageof 6
CNS Spectrums|December 14, 2005
Long-term safety and effectiveness of mixed amphetamine salts extended release in adults with ADHDJoseph Biederman, Thomas J Spencer, Timothy E Wilens, et al.The Journal of Clinical Psychiatry|November 18, 2008
Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorderLenard A Adler, David W Goodman, Scott H Kollins, et al.The Journal of Clinical Psychiatry|November 26, 2008
Attention-deficit/hyperactivity disorder-specific quality of life with triple-bead mixed amphetamine salts (SPD465) in adults: results of a randomized, double-blind, placebo-controlled studyThomas J Spencer, Jeanne M Landgraf, Lenard A Adler, et al.The Journal of Clinical Psychiatry|March 16, 2005
Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trialRichard H Weisler, Paul E Keck, Alan C Swann, et al.Journal of Affective Disorders|June 7, 2005
Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trialDennis A Revicki, Robert M A Hirschfeld, Eileen P Ahearn, et al.The Journal of Clinical Psychiatry|August 16, 2013
Lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder who report clinically significant impairment in executive function: results from a randomized, double-blind, placebo-controlled studyLenard A Adler, Bryan Dirks, Patrick F Deas, et al.CNS Spectrums|July 27, 2005
Reassessing carbamazepine in the treatment of bipolar disorder: clinical implications of new dataHagop S Akiskal, Matthew A Fuller, Robert M A Hirschfeld, et al.Journal of Clinical Psychopharmacology|March 2, 2005
Maintenance therapy with fluoxetine in posttraumatic stress disorder: a placebo-controlled discontinuation studyJonathan R T Davidson, Kathryn M Connor, Michael A Hertzberg, et al.Neuropsychiatric Disease and Treatment|December 24, 2013
Analysis of individual items on the attention-deficit/hyperactivity disorder symptom rating scale in children and adults: the effects of age and sex in pivotal trials of lisdexamfetamine dimesylateRichard H Weisler, Lenard A Adler, Scott H Kollins, et al.CNS Drugs|March 15, 2006
Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trialsRichard H Weisler, Robert Hirschfeld, Andrew J Cutler, et al.Pageof 6